| Early Aggressive Therapy in Juvenile Idiopathic Arthritis |
|
| R01 AR 049762 | 09/01/06 - 08/31/11 |
$87,814 / $719,397 |
| Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomytosis |
|
| N01 AR 042273 | 09/01/06 - 09/29/09 |
$56,674 / $170,022 |
| Cincinnati Multidisciplinary Clinical Research Center |
|
| P60 AR 047784 | 08/18/08 - 07/31/13 |
$825,653 / $4,210,600 |
| Lovell, D | Administrative Core | 66,866 |
|
| Giannini, E | Methodology Core | 105,190 |
|
| Brunner, H | Project 1 | 160,309 |
|
| Lovell, D | Project 2 | 184,861 |
|
|
|
| Dynamic Outcome Assessment in Multicenter Trials |
|
| U01 AR 052186 | 08/01/08 - 07/31/09 |
$18,333 / $18,333 |
| Cincinnati Rheumatic Diseases Core Center |
|
| P30 AR 047363 | 09/01/06 - 06/30/11 |
$388,400 / $2,000,000 |
| Thompson, S | Administrative Core | 56,586 |
|
| Thompson, S | Core 1 - Tissue | 43,042 |
|
| Degen, J | Core 2 - Animal Models of Arthritis/Inflammatory Disease | 67,299 |
|
| Thornton, S | Core 3 - Phenotyping | 79,978 |
|
| Wagner, M | Core 4 - Informatics | 41,495 |
|
|
|
| Prevention of Cardiovascular Complications of Pediatric Lupus |
|
| N01AR022265 | 9/30/02 - 8/31/08 |
$26,873 / $ 134,367 |
| Early Agressive Therapy in JIA |
|
| R01AR049762 | 05/01/08 - 04/30/11 |
$42,809 / $85,619 |